Results 271 to 280 of about 382,621 (326)

Vaccination Recommendations in Patients With Atopic Dermatitis Treated With JAK Inhibitors

open access: yesInternational Journal of Dermatology, Volume 65, Issue 2, Page 230-237, February 2026.
Inmunization and Screening Protocol for the Safe Initiation of JAK Inhibitors. ABSTRACT Atopic dermatitis therapy has undergone a revolutionary change with the introduction of Janus kinase (JAK) inhibitors. Despite their general safety profile, these immunomodulatory drugs require special precautions with respect to infection risk and vaccine ...
Mariano Ara‐Martín   +5 more
wiley   +1 more source

Manipulation of the Unfolded Protein Response by Intracellular Bacterial Pathogens: Mechanisms of ER Hijacking and Therapeutic Implications

open access: yesThe FASEB Journal, Volume 40, Issue 2, 31 January 2026.
This review illustrates how intracellular bacterial pathogens—such as Brucella, Mycobacterium tuberculosis, and Legionella—secrete effector proteins that specifically target the IRE1α, PERK, and ATF6 branches of the unfolded protein response (UPR) to hijack ER stress signaling.
Enhui Dai   +5 more
wiley   +1 more source

Oligomerization is required for channel formation of MctB and for copper resistance of Mycobacterium tuberculosis. [PDF]

open access: yesJ Biol Chem
Siroy A   +7 more
europepmc   +1 more source

Tibial osteitis caused by Mycobacterium tuberculosis. [PDF]

open access: yesAccess Microbiol
Benjelloun M   +4 more
europepmc   +1 more source

Erythromycin Shortage in an NTM‐Endemic Country: Implications for Bronchiectasis Care and Antimicrobial Stewardship

open access: yes
Respirology, Volume 31, Issue 2, Page 132-134, February 2026.
Takanori Asakura, Ho Namkoong
wiley   +1 more source

Phylodynamic analysis reveals disparate transmission dynamics of Mycobacterium tuberculosis complex lineages in Botswana. [PDF]

open access: yesSci Rep
Wang Q   +12 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy